| Dr Peter Bryan Boggs, MD | |
|
2300 Hospital Dr Ste 345, Bossier City, LA 71111-2194 | |
| (318) 212-7808 | |
| (318) 212-7348 |
| Full Name | Dr Peter Bryan Boggs |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 58 Years |
| Location | 2300 Hospital Dr Ste 345, Bossier City, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447217252 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KI0005X | Allergy & Immunology - Clinical & Laboratory Immunology | 009735 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Willis Knighton Medical Center, Inc | Shreveport, LA | Hospital |
| Entity Name | Louisiana State University Health Sciences Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417992249 PECOS PAC ID: 6103730908 Enrollment ID: O20031208000275 |
News Archive
As the flu season continues in full-swing, most people can appreciate the need for drugs that stop viruses after they take hold in the body. Despite this serious need for new drugs, a team of researchers from the University of Texas at Austin raise serious concerns about an emerging strategy for stopping viral infections.
The Food and Drug Administration (FDA) and California's Department of Health Services (CDHS) have released a joint report on an extensive investigation into the causes of an E.coli O157:H7 outbreak last fall that was associated with contaminated Dole brand Baby Spinach and resulted in 205 confirmed illnesses and three deaths.
Cerenis Therapeutics, the biopharmaceutical company, today announced that its Phase IIb CHI-SQUARE (Can HDL Infusions Significantly Quicken Atherosclerosis REgression?) study did not reach its primary endpoint in post-Acute Coronary Syndrome patients.
The Office for Victims of Crime (OVC), in the Department of Justice's Office for Justice Programs, plans to award up to $750,000 over three years in funding dedicated to helping American victims of domestic violence overseas. This is the first year OVC awarded the funding.
› Verified 2 days ago
| Entity Name | Wk Allergy And Asthma Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760939987 PECOS PAC ID: 1254619356 Enrollment ID: O20161025000235 |
News Archive
As the flu season continues in full-swing, most people can appreciate the need for drugs that stop viruses after they take hold in the body. Despite this serious need for new drugs, a team of researchers from the University of Texas at Austin raise serious concerns about an emerging strategy for stopping viral infections.
The Food and Drug Administration (FDA) and California's Department of Health Services (CDHS) have released a joint report on an extensive investigation into the causes of an E.coli O157:H7 outbreak last fall that was associated with contaminated Dole brand Baby Spinach and resulted in 205 confirmed illnesses and three deaths.
Cerenis Therapeutics, the biopharmaceutical company, today announced that its Phase IIb CHI-SQUARE (Can HDL Infusions Significantly Quicken Atherosclerosis REgression?) study did not reach its primary endpoint in post-Acute Coronary Syndrome patients.
The Office for Victims of Crime (OVC), in the Department of Justice's Office for Justice Programs, plans to award up to $750,000 over three years in funding dedicated to helping American victims of domestic violence overseas. This is the first year OVC awarded the funding.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Bryan Boggs, MD 2300 Hospital Dr Ste 345, Bossier City, LA 71111-2194 Ph: (318) 212-7808 | Dr Peter Bryan Boggs, MD 2300 Hospital Dr Ste 345, Bossier City, LA 71111-2194 Ph: (318) 212-7808 |
News Archive
As the flu season continues in full-swing, most people can appreciate the need for drugs that stop viruses after they take hold in the body. Despite this serious need for new drugs, a team of researchers from the University of Texas at Austin raise serious concerns about an emerging strategy for stopping viral infections.
The Food and Drug Administration (FDA) and California's Department of Health Services (CDHS) have released a joint report on an extensive investigation into the causes of an E.coli O157:H7 outbreak last fall that was associated with contaminated Dole brand Baby Spinach and resulted in 205 confirmed illnesses and three deaths.
Cerenis Therapeutics, the biopharmaceutical company, today announced that its Phase IIb CHI-SQUARE (Can HDL Infusions Significantly Quicken Atherosclerosis REgression?) study did not reach its primary endpoint in post-Acute Coronary Syndrome patients.
The Office for Victims of Crime (OVC), in the Department of Justice's Office for Justice Programs, plans to award up to $750,000 over three years in funding dedicated to helping American victims of domestic violence overseas. This is the first year OVC awarded the funding.
› Verified 2 days ago